TABLE 2.
Mean detectability |
|||||
Patient no. | Lesions (n) | Localization | Standard dose | Low dose | Very low dose |
1 | 1 | LN | 3 | 2 | 1 |
2 | 2 | LR | 3 | 3 | 2 |
3 | 3 | Prostate | 3 | 3 | 2.67 |
4 | Bone | 2 | 2.33 | 0.33 | |
4 | 5 | LR | 0.67 | 0 | 0 |
5 | 6 | LN | 3 | 2.67 | 1.67 |
7 | LN | 3 | 2.67 | 1.67 | |
8 | LN | 2.67 | 2.67 | 1.67 | |
9 | LN | 3 | 2.33 | 1 | |
10 | LN | 2 | 1.67 | 1.33 | |
6 | 11 | LN | 3 | 2.33 | 2.33 |
12 | LN | 2 | 1.33 | 1 | |
13 | Prostate | 2 | 2.67 | 0.67 | |
14 | LN | 2 | 1.67 | 0 | |
15 | LN | 2 | 1.67 | 0 | |
7 | 16 | LN | 3 | 3 | 3 |
17 | LN | 2.67 | 2.33 | 0.67 | |
18 | LR | 3 | 3 | 3 | |
8 | 19 | LR | 3 | 1 | 3 |
20 | Bone | 1.67 | 1.67 | 0.33 | |
10 | 21 | LN | 3 | 3 | 1 |
LN = lymph node; LR = local recurrence.